24 related articles for article (PubMed ID: 38442593)
1. Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML).
Tawfik B; Pardee TS; Isom S; Sliesoraitis S; Winter A; Lawrence J; Powell BL; Klepin HD
J Geriatr Oncol; 2016 Jan; 7(1):24-31. PubMed ID: 26527394
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of the ID1 expression in acute myeloid leukemia patients treated in a resource-constrained setting.
Lima AS; Bezerra MF; Moreira-Aguiar A; Weinhäuser I; Santos BL; Falcão RM; Salustiano-Bandeira ML; Franca-Neto PL; Lima MM; Saldanha-Araujo F; Coelho-Silva JL; Pereira-Martins DA; Bezerra MA; Lucena-Araujo AR
Hematol Transfus Cell Ther; 2024; 46(3):250-255. PubMed ID: 37393163
[TBL] [Abstract][Full Text] [Related]
3. [Outcomes of adult patients with
Ren X; Zhao T; Wang J; Zhu HH; Jiang H; Jia JS; Yang SM; Jiang B; Wang DB; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2018 Jan; 39(1):15-21. PubMed ID: 29551027
[No Abstract] [Full Text] [Related]
4. [Prognostic significance of blood count at the time of achieving morphologic leukemia-free state in adults with acute myeloid leukemia].
Ren X; Zhao T; Wang J; Zhu HH; Jiang H; Jia JS; Yang SM; Jiang B; Wang DB; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):185-191. PubMed ID: 28395440
[No Abstract] [Full Text] [Related]
5. [Treatment responses, outcomes, and prognostic factors associated with them in patients with secondary acute myeloid leukemia].
Ma L; Zhao T; Chen YY; Jiang H; Xu LP; Zhang XH; Wang Y; Sun YQ; Mo XD; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):124-131. PubMed ID: 36948866
[No Abstract] [Full Text] [Related]
6. Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice.
Apel A; Moshe Y; Ofran Y; Gural A; Wolach O; Ganzel C; Canaani J; Zektser M; Duek A; Stemer G; Hellman I; Basood M; Frisch A; Leibovitch C; Koren-Michowitz M
Am J Hematol; 2021 Jul; 96(7):790-795. PubMed ID: 33836555
[TBL] [Abstract][Full Text] [Related]
7. Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.
Gangat N; Karrar O; Iftikhar M; McCullough K; Johnson IM; Abdelmagid M; Abdallah M; Al-Kali A; Alkhateeb HB; Begna KH; Mangaonkar A; Saliba AN; Hefazi Torghabeh M; Litzow MR; Hogan W; Shah M; Patnaik MM; Pardanani A; Badar T; Murthy H; Foran J; Palmer J; Sproat L; Khera N; Arana Yi C; Tefferi A
Am J Hematol; 2024 Feb; 99(2):193-202. PubMed ID: 38071734
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of patients with acute myeloid leukemia and cardiovascular disease.
Sanchez-Petitto G; Goloubeva OG; Masur J; Childress J; Iqbal T; An M; Muhammad S; Lawson J; Li G; Barr B; Emadi A; Law JY; Lee ST; Duong VH; Baer MR; Niyongere S
Leuk Res; 2024 Mar; 138():107456. PubMed ID: 38442593
[TBL] [Abstract][Full Text] [Related]
9. Impact on acute myeloid leukemia relapse in granulocyte colony-stimulating factor application: a meta-analysis.
Feng X; Lan H; Ruan Y; Li C
Hematology; 2018 Oct; 23(9):581-589. PubMed ID: 29516766
[TBL] [Abstract][Full Text] [Related]
10. The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia.
Li X; Xu S; Tan Y; Chen J
Cochrane Database Syst Rev; 2015 Jun; (6):CD010432. PubMed ID: 26037486
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission.
Mao C; Fu XH; Yuan JQ; Yang ZY; Huang YF; Ye QL; Wu XY; Hu XF; Zhai ZM; Tang JL
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010248. PubMed ID: 26544114
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup.
Delaunay J; Vey N; Leblanc T; Fenaux P; Rigal-Huguet F; Witz F; Lamy T; Auvrignon A; Blaise D; Pigneux A; Mugneret F; Bastard C; Dastugue N; Van den Akker J; Fière D; Reiffers J; Castaigne S; Leverger G; Harousseau JL; Dombret H; ; ; ; ;
Blood; 2003 Jul; 102(2):462-9. PubMed ID: 12649129
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]